New Product Briefs: St. Jude TAVR Update; ADHD, GI Tests Launch
This article was originally published in The Gray Sheet
St. Jude expects to receive a CE mark for a transfemoral 25 millimeter version of its Portico transcatheter aortic valve replacement system during the fourth quarter. NEBA Health launches ADHD test. Exalenz BioScience launches test for H. pylori stomach bacteria.
You may also be interested in...
FDA proposes class II for nonthermal shortwave therapy devices and updates regulations to reflect class II designation for neuropsychiatric assessment device. Meetings on manufacturing quality, clinical trials and medical countermeasures announced. More regulatory news.
St. Jude Medical’s Portico transcatheter aortic valve is poised to become more competitive in Europe in 2014 as more sizes become available, executives told investors during the firm’s Feb. 7 annual investor conference. And the firm is talking to FDA about alternative pivotal trial designs.
ImmunID names president and CEO. Natural Molecular Testing Corp. appoints CFO. Biolase taps VP of marketing. New VP of sales at Exalenz Bioscience.